Treating obesity with sibutramine under practical conditions. Positive effects on the metabolic parameters and blood pressure.

Treating obesity with sibutramine under practical conditions. Positive effects on the metabolic parameters and blood pressure.

Bibliographic Details
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2005-06-01
Series:	Ожирение и метаболизм
Online Access:	https://endojournals.ru/index.php/omet/article/view/4932

Similar Items

Can sibutramine alter systemic blood pressure in obese patients? Systematic review and meta-analysis
by: Hernani Pinto de Lemos Júnior, et al.

Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension
by: Alessandra Nunes Faria, et al.
Published: (2002-02-01)

Behavior therapy and Sibutramine for the treatment of adolescent obesity.
Published: (2005-06-01)

Sibutramine monotherapy in arterial hypertension combined with obesity
by: S. V. Nedogoda, et al.
Published: (2009-08-01)

Cardiovascular effects of sibutramine
by: Woolard, Jeanette
Published: (2002)

Central mechanisms regulating energy metabolism and sibutramine
Published: (2012-09-01)

The use of sibutramine in the management of obesity and related disorders: An update
by: Konstantinos Tziomalos, et al.
Published: (2009-05-01)

The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment
by: S. O'Meara, et al.
Published: (2002-01-01)

Modulation of central noradrenergic function by the anti-obesity agent, sibutramine
by: Wortley, Katherine Emily
Published: (2000)

The experience of sibutramine administration in patients with obesity and controlled arterial hypertension
by: Elena Y. Shupenina, et al.
Published: (2019-09-01)

Sibutramine: Myths and Realities
by: Marina Olegovna Galieva, et al.
Published: (2014-10-01)

Sibutramine versus Metformin: assessment of anthropometric, lipid and glycemic parameters in obese and overweight high-risk patients
by: Camilo Molino Guidoni, et al.
Published: (2012-01-01)

Sibutramine versus Metformin: assessment of anthropometric, lipid and glycemic parameters in obese and overweight high-risk patients
by: Leonardo Regis Leira Pereira
Published: (2012-01-01)

Sibutramine: efficacy and safety of prescribing in routine clinical practice
by: Tat'yana Ivanovna Romantsova
Published: (2015-11-01)

Effect of sibutramine on cardiovascular events when administered in routine clinical practice
by: Nadezhda Sergeevna Dalantaeva
Published: (2015-08-01)

Sibutramin v lechenii ozhireniya
Published: (2010-06-01)

Experience of using sibutramine in combination with microcrystalline cellulose in clinical practice
by: N. A. Petunina, et al.
Published: (2020-01-01)

Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients
by: Alfredo Halpern, et al.
Published: (2010-01-01)

Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study
by: Panagiotis Anagnostis, et al.
Published: (2012-01-01)

An in vivo and in ovo evaluation of the toxicity of Sibutramine
by: Van der Schoor, Ciska
Published: (2015)

Effect of sibutramine on macronutrient selection in male and female rats
by: LeBlanc, Marisa
Published: (2003)

Effects of One Year Treatment of Sibutramine on Insulin Resistance Parameters in Type 2 Diabetic Patients
by: Giuseppe Derosa, et al.
Published: (2010-09-01)

Therapy of obesity by sibutramin: polymorphisms of TPH2 and GNB3 genes and decrease of body weight
by: Marina O. Galieva, et al.
Published: (2018-07-01)

The role of genetic factors in predicting results of obesity treatment with sibutramine – serotonin-norepinephrine reuptake inhibitor
by: Marina Galieva, et al.
Published: (2016-12-01)

Sibutramine as a Cause of Sudden Cardiac Death
by: Miguel Rodriguez-Guerra, et al.
Published: (2021-01-01)

Voltammetric determination of sibutramine in beverages and in pharmaceutical formulations
by: Juliana M. Carvalho, et al.
Published: (2012-01-01)

Analytical Methodologies for the Stereoselective Determination of Sibutramine: An Overview
by: Vlad Alexandru Robert, et al.
Published: (2017-06-01)

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study
Published: (2008-12-01)

CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM
by: E. A. Troshina, et al.
Published: (2017-12-01)

Misuse of sibutramine and bulimia nervosa: a dangerous combination
by: Gabriela Mourão Ferreira, et al.

Sibutramine-induced mania as the first manifestation of bipolar disorder
by: Waszkiewicz Napoleon, et al.
Published: (2012-05-01)

An electrophysiological and neuropharmacological study of sibutramine hydrochloride and its metabolites
by: Mahony, Mary Teresa
Published: (1990)

Development and Validation of Sibutramine Determination in Drug Products by Capillary Electrophoresis
by: A. M. Sukhanova, et al.
Published: (2020-11-01)

USE OF SIBUTRAMIN IN PHARMACEUTICAL DRUGS AND ANOREXIC DIETARY SUPPLEMENTS (REVIEW)
by: A. M. Sukhanova, et al.
Published: (2019-02-01)

Impact of sibutramine (meridia) on body composition, peptide YY3-36 and serotonin levels in patients with exogenous constitutional obesity
by: Yu Yu Vlasova, et al.
Published: (2010-08-01)

Metabolic evaluation in overweight and obese cats and association with blood pressure
by: Vanessa Danielle de Freitas, et al.
Published: (2017-12-01)

A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
by: Somaye Fatahi, et al.
Published: (2018-09-01)

Sibutramine: balanced judgment or prejudice? Sibutramina: julgamento equilibrado ou preconceito?
by: Walmir Coutinho, et al.
Published: (2011-06-01)

Herbal Weight Loss Pill Overdose: Sibutramine Hidden in Pepper Pill
by: Gul Pamukcu Gunaydin, et al.
Published: (2015-01-01)

Use of sibutramine hydrochloride monohydrate in the treatmentof the painful peripheral neuropathy of diabetes
Published: (2009-09-01)

Cannot write session to /tmp/vufind_sessions/sess_jcjpl04a4pr2dn3esfctj8n3d1